Determinants of ovarian function after response-adapted therapy in patients with advanced Hodgkin's lymphoma (RATHL): a secondary analysis of a randomised phase 3 trial-Reference-Cited by-同舟云学术

Determinants of ovarian function after response-adapted therapy in patients with advanced Hodgkin's lymphoma (RATHL): a secondary analysis of a randomised phase 3 trial

Published:2018-10 Issue:10 Volume:19 Page:1328-1337
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Anderson Richard A,Remedios Rachel,Kirkwood Amy A,Patrick Pip,Stevens Linsey,Clifton-Hadley Laura,Roberts Tom,Hatton Chris,Kalakonda Nagesh,Milligan Don W,McKay Pam,Rowntree Clare,Scott Fiona M,Johnson Peter W M

Publisher

Elsevier BV

Subject

Oncology

Reference29 articles.

1. Randomized comparison of the stanford V regimen and ABVD in the treatment of advanced Hodgkin's lymphoma: United Kingdom National Cancer Research Institute Lymphoma Group Study ISRCTN 64141244;Hoskin;J Clin Oncol,2009

2. Risk of premature menopause after treatment for Hodgkin's lymphoma;Swerdlow;J Natl Cancer Inst,2014

3. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group;Behringer;J Clin Oncol,2005

4. Cortical fibrosis and blood-vessels damage in human ovaries exposed to chemotherapy. Potential mechanisms of ovarian injury;Meirow;Hum Reprod,2007

5. Pretreatment serum anti-müllerian hormone predicts long-term ovarian function and bone mass after chemotherapy for early breast cancer;Anderson;J Clin Endocrinol Metab,2011

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What reproductive follow-up for adolescent and young women after cancer? A review;Reproductive BioMedicine Online;2024-07

2. Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial;The Lancet;2024-07

3. Fertilité et greffe de cellules souches hématopoïétiques (SFGM-TC);Bulletin du Cancer;2024-06

4. The impact of treatment for childhood classical Hodgkin lymphoma according to the EuroNet-PHL-C2 protocol on serum anti-Müllerian Hormone;Human Reproduction;2024-05-24

5. Pharmacological methods for ovarian function and fertility preservation in women with cancer: A literature review;Oncology Research;2024